DR. LEONG ANNIE

Medical Lecturer

ACADEMIC QUALIFICATION

ASIA PACIFIC PAEDIATRIC ENDOCRINE SOCIETY (APPES), MEMBER
2020 to present (International)
MALAYSIAN ENDOCRINE & METABOLIC SOCIETY (MEMS), MEMBER
2018 to present (National)
MALAYSIAN MEDICAL ASSOCIATION (MMA), MEMBER
Since 2002 (National)

Leong, A., & Vasanwala, R. F. (2024). Early Puberty Trend during the COVID-19 Pandemic in Singapore : A Retrospective Review in a Single Tertiary Centre. Journal of the ASEAN Federation of Endocrine Societies, 39(1), 6–11. https://doi.org/10.15605/jafes.039.01.12

2024 - 2029, Globe-Reg
Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions (Globe-Reg), University of Glasgow, Scotland ( Co-Researcher)
2024 - 2027, Novo Nordisk Pharma (Malaysia) Sdn. Bhd
A Study comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin as well as evaluating long term safety of somapacitan in a basket study design in children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)
2024 - 2027, Novo Nordisk Pharma (Malaysia) Sdn. Bhd.
A study evaluating the safety and efficacy of once-weekly dosing of somapacitan in a basket study design in paediatric participants with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome or idiopathic short stature, University Malaya Medical Centre (UMMC) (Pusat Perubatan Universiti Malaya)(PPUM) ( Co-Researcher)